(Q44582125)

4 December 2017

Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas (English)

1 reference

invasive ductal carcinoma

4 December 2017

0 references

1 reference

1 reference

9

Günter Klöppel

1 reference

4 December 2017

Nobuyuki Ohike

1

1 reference

4 December 2017

Nicolai Maass

2

1 reference

4 December 2017

Christoph Mundhenke

3

1 reference

4 December 2017

Marco Biallek

4

1 reference

4 December 2017

Ming Zhang

5

1 reference

4 December 2017

Walter Jonat

6

1 reference

4 December 2017

Jutta Lüttges

7

1 reference

4 December 2017

Toshio Morohoshi

8

1 reference

4 December 2017

Koichi Nagasaki

10

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

199

1 reference

4 December 2017

2

1 reference

4 December 2017

193-200

1 reference

Prognostic factors in ductal pancreatic cancer

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Maspin expression in stage I and II oral tongue squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Immunohistochemical analysis of cyclooxygenase (COX)-2 expression in pancreatic endocrine tumors: association with tumor progression and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

p53 overexpression in lymph node metastases predicts clinical outcome in ductal pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

p53 regulates the expression of the tumor suppressor gene maspin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

Role for DNA methylation in the control of cell type specific maspin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2803%2900390-2

7 January 2021

10.1016/S0304-3835(03)00390-2

Identifiers

DOI

1 reference

4 December 2017

1 reference